Abuse resistant capsule
US12133922B2 · kind B2 · utility
0Cited by
15References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 19, 2022 |
| Grant date | Nov 5, 2024 |
| Priority date | — |
| Expiry date | Jul 19, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to an immediate release and extended release capsule or capsule fill which mitigates the abuse of abuse-susceptible active pharmaceutical ingredients by direct intravenous injection. The fill comprises a parenteral abuse resistant liquid formulation which when mixed with water and heated, results in a turbid, viscous or bubbling mixture that is not injectable with a standard insulin syringe. The abuse-susceptible active pharmaceutical ingredient is selected from the group consisting of opiates, opioids, tranquillizers, stimulants and narcotics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.